KRAS and pancreatic neoplasm: Lastly, the KRAS cell‐free DNA mutations could be detected in 3.7% of healthy controls and in 4.3% of patients with chronic pancreatitis in a study focused on pancreatic cancer detection (Calvez‐Kelm et al., 2016).